Characterizing dedifferentiation of thyroid cancer by integrated analysis-Reference-Cited by-同舟云学术

Characterizing dedifferentiation of thyroid cancer by integrated analysis

Published:2021-07-30 Issue:31 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Luo Han¹^ORCID,Xia Xuyang²^ORCID,Kim Gyeong Dae³^ORCID,Liu Yang¹^ORCID,Xue Zhinan²,Zhang Lingyun¹,Shu Yang²⁴^ORCID,Yang Tian⁵^ORCID,Chen Yan²,Zhang Shouyue²^ORCID,Chen Haining⁴^ORCID,Zhang Weihan⁴^ORCID,Li Ruicen⁶,Tang Huairong⁶,Dong Birong⁷,Fu Xianghui²^ORCID,Cheng Wei²,Zhang Wei⁸,Yang Li²^ORCID,Peng Yong²^ORCID,Dai Lunzhi²^ORCID,Hu Hongbo²^ORCID,Jiang Yong⁵,Gong Changyang²,Hu Yiguo¹²^ORCID,Zhu Jingqiang¹^ORCID,Li Zhihui¹,Caulin Carlos⁹^ORCID,Wei Tao¹^ORCID,Park Jihwan³^ORCID,Xu Heng²¹⁰^ORCID

Affiliation:

1. Department of Thyroid and Parathyroid Surgery, Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China.

3. School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea.

4. Department of Gastrointestinal Surgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

5. Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

6. Health Promotion Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

7. National Clinical Research Center for Geriatrics, Chengdu, Sichuan, China.

8. Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, Hunan, China.

9. Department of Otolaryngology—Head & Neck Surgery and University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.

10. Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Abstract

Clinical staining and targeting CREB3L1 facilitates precise stratification and a potential treatment strategy for thyroid cancer.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

National Key Research and Development Program of China Stem Cell and Translational Research

Samsung Science and Technology Foundation

Sichuan Science and Technology Program

Post-Doctor Research Project, West China Hospital, Sichuan University

1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University

International Cooperation Project of Chengdu Municipal Science and Technology Bureau

Publisher